{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:50:07Z","timestamp":1790815807431,"version":"4.1.0"},"reference-count":62,"publisher":"Oxford University Press (OUP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2004,12,1]]},"DOI":"10.1095\/biolreprod.104.032870","type":"journal-article","created":{"date-parts":[[2004,10,20]],"date-time":"2004-10-20T18:43:47Z","timestamp":1098297827000},"page":"2037-2047","source":"Crossref","is-referenced-by-count":19,"title":["PHI-443: A Novel Noncontraceptive Broad-Spectrum Anti-Human Immunodeficiency Virus Microbicide1"],"prefix":"10.1093","volume":"71","author":[{"given":"Osmond J.","family":"D\u2019Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Samuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatih M.","family":"Uckun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"key\n\t\t\t\t20170224021143_R1","unstructured":"United Nations Program on HIV\/AIDS. AIDS epidemic update. Available at: www.unaids.org. Accessed December 2003"},{"key":"key\n\t\t\t\t20170224021143_R2","unstructured":"National Institute of Allergy and Infectious Diseases Fact Sheet. HIV infection in women. Fact sheet. Available at: http:\/\/www.niaid.nih.gov\/factsheets\/womenhiv.htm. Accessed December 2003"},{"key":"key\n\t\t\t\t20170224021143_R3","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/13543784.11.8.1077","article-title":"Considerations and development of topical microbicides to inhibit the sexual transmission of HIV","volume":"11","year":"2002","journal-title":"Expert Opin Investig Drugs"},{"key":"key\n\t\t\t\t20170224021143_R4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.2174\/1381612043386374","article-title":"Clinical development of microbicides for the prevention of HIV infection","volume":"10","year":"2004","journal-title":"Curr Pharm Des"},{"key":"key\n\t\t\t\t20170224021143_R5","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1056\/NEJM198710293171806","article-title":"Transmission of the human immunodeficiency virus","volume":"317","year":"1987","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170224021143_R6","first-page":"506","article-title":"Prophylactic contraceptives for HIV\/AIDS","volume":"5","year":"1998","journal-title":"Hum Reprod Update"},{"key":"key\n\t\t\t\t20170224021143_R7","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1095\/biolreprod63.1.196","article-title":"Novel thiourea compounds as dual-function microbicides","volume":"63","year":"2000","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224021143_R8","first-page":"15","article-title":"Preclinical overview of WHI-07, a novel nucleoside analogue-based dual function microbicide","volume":"3","year":"2004","journal-title":"Curr Med Chem"},{"key":"key\n\t\t\t\t20170224021143_R9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/jac\/dkg001","article-title":"Pre-clinical safety evaluation of novel nucleoside analogue-based dual-function microbicides (WHI-05 and WHI-07)","volume":"50","year":"2002","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t20170224021143_R10","article-title":"Study finds drug-resistant HIV in half of infected patients","year":"2001","journal-title":"Washington Post"},{"key":"key\n\t\t\t\t20170224021143_R11","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(02)07249-5","article-title":"Many HIV patients carry mutated drug-resistant strains","volume":"359","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170224021143_R12","doi-asserted-by":"crossref","first-page":"5633","DOI":"10.1074\/jbc.275.8.5633","article-title":"Phenylethylthiazolylthiourea (PETT) non-nucleoside inhibitors of HIV-1 and HIV-2 reverse transcriptases. Structural and biochemical analyses","volume":"275","year":"2000","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20170224021143_R13","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1021\/jm950639r","article-title":"Morin JM Jr, Muesing MA, Noreen R, Oberg B, Pranc P, Sahlberg C, Ternansky RJ, Vasileff RT, Vrang L, West SJ, Zhang H. Phenethylthiazolylthiourea (PETT) compounds as a new class of HIV-1 reverse transcriptase inhibitors. 2. Synthesis and further structure-activity relationship studies of PETT analogs","volume":"39","year":"1996","journal-title":"J Med Chem"},{"key":"key\n\t\t\t\t20170224021143_R14","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2174\/1568026033451754","article-title":"Nonnucleoside inhibitors of HIV-1 reverse transcriptase: from the biology of reverse transcription to molecular design","volume":"3","year":"2003","journal-title":"Curr Top Med Chem"},{"key":"key\n\t\t\t\t20170224021143_R15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1386-6532(01)00167-6","article-title":"Antiviral drugs: current state of the art","volume":"22","year":"2001","journal-title":"J Clin Virol"},{"key":"key\n\t\t\t\t20170224021143_R16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1128\/AAC.48.1.172-175.2004","article-title":"Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs","volume":"48","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170224021143_R17","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1002\/jcc.1133","article-title":"Conformational analysis of the HIV-1 virus reverse transcriptase nonnucleoside inhibitors: TIBO and nevirapine","volume":"22","year":"2001","journal-title":"J Comput Chem"},{"key":"key\n\t\t\t\t20170224021143_R18","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1086\/383572","article-title":"Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy","volume":"38","year":"2004","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t20170224021143_R19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/jmbi.1998.2171","article-title":"Clark AD Jr, Kleim JP, Rosner M, Winkler I, Riess G, Hughes SH, Arnold E. Structure of tyr188Leu mutant and wild-type HIV-1 reverse transcriptase complexed with the non-nucleoside inhibitor HBY 097: inhibitor flexibility is a useful design feature for reducing drug resistance","volume":"284","year":"1998","journal-title":"J Mol Biol"},{"key":"key\n\t\t\t\t20170224021143_R20","first-page":"365","article-title":"Clark AD Jr, Jessen S, Lu X, Hsiou Y, Jacobo-Molina A, Andries K, Pauwels R, Moereels H, Koymans L, Janssen PAJ, Smith RHJ, Kroeger-Koepke R, Michejda CJ, Hughes SH, Arnold E. Structure of HIV-1 reverse transcriptase in a complex with the non-nucleoside inhibitor alpha-APA R 95845 at 2.8 A resolution","volume":"3","year":"1995","journal-title":"Structure"},{"key":"key\n\t\t\t\t20170224021143_R21","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1126\/science.1377403","article-title":"Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor","volume":"256","year":"1992","journal-title":"Science"},{"key":"key\n\t\t\t\t20170224021143_R22","doi-asserted-by":"crossref","first-page":"3911","DOI":"10.1073\/pnas.91.9.3911","article-title":"Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1","volume":"91","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"key\n\t\t\t\t20170224021143_R23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/S0968-0896(98)00108-4","article-title":"Rational design and synthesis of phenethyl-5-bromopyridyl thiourea derivatives as potent non-nucleoside inhibitors of HIV reverse transcriptase","volume":"6","year":"1998","journal-title":"Bioorg Med Chem"},{"key":"key\n\t\t\t\t20170224021143_R24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1056\/NEJM200108093450602","article-title":"Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection","volume":"345","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170224021143_R25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/095632029901000502","article-title":"Structure-based design of non-nucleoside reverse transcriptase inhibitors of drug-resistant human immunodeficiency virus","volume":"10","year":"1999","journal-title":"Antivir Chem Chemother"},{"key":"key\n\t\t\t\t20170224021143_R26","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0006-2952(00)00408-1","article-title":"Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase","volume":"60","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"key\n\t\t\t\t20170224021143_R27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/jmv.2055","article-title":"Resistance profile and cross-resistance of HIV-1 among patients failing a non-nucleoside reverse transcriptase inhibitor-containing regimen","volume":"65","year":"2001","journal-title":"J Med Virol"},{"key":"key\n\t\t\t\t20170224021143_R28","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1126\/science.282.5394.1669","article-title":"Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance","volume":"282","year":"1998","journal-title":"Science"},{"key":"key\n\t\t\t\t20170224021143_R29","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1128\/AAC.42.12.3225","article-title":"Structure-based design of novel dihydroalkoxybenzyloxopyrimidine derivatives as potent nonnucleoside inhibitors of the human immunodeficiency virus reverse transcriptase","volume":"42","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170224021143_R30","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1016\/S0960-894X(99)00624-1","article-title":"N\u2032-[2-(2-thiophene)ethyl]-N\u2032-[2-(5-bromopyridyl)] thiourea as a potent inhibitor of NNI-resistant and multidrug-resistant human immunodeficiency virus-1","volume":"9","year":"1999","journal-title":"Bioorg Med Chem Lett"},{"key":"key\n\t\t\t\t20170224021143_R31","doi-asserted-by":"crossref","first-page":"3613","DOI":"10.1128\/AAC.46.11.3613-3616.2002","article-title":"Stampidine is a potent inhibitor of zidovudine- and nucleoside analogue reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analogue mutations","volume":"46","year":"2002","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t20170224021143_R32","first-page":"69","article-title":"In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates","volume":"54","year":"2004","journal-title":"Arzneimittelforschung"},{"key":"key\n\t\t\t\t20170224021143_R33","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1097\/00002030-200111230-00003","article-title":"Vaginal transmission of HIV-1 in hu-SCID mice: a new model for the evaluation of vaginal microbicides","volume":"15","year":"2001","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170224021143_R34","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1128\/AAC.42.2.383","article-title":"TXU(Anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus","volume":"42","year":"1998","journal-title":"Antimicrobial Agents Chemother"},{"key":"key\n\t\t\t\t20170224021143_R35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/molehr\/5.5.421","article-title":"Shih M-J, Yiv SH, Chen CL, Uckun FM. Synthesis, characterization, and preclinical formulation of a dual-action phenyl phosphate derivative of bromo-methoxy zidovudine (compound WHI-07) with potent anti-HIV and spermicidal activities","volume":"5","year":"1999","journal-title":"Mol Hum Reprod"},{"key":"key\n\t\t\t\t20170224021143_R36","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1095\/biolreprod.102.006478","article-title":"Structural requirements for potent anti-human immunodeficiency virus (HIV) and sperm-immobilizing activities of cyclohexenyl thiourea and urea non-nucleoside inhibitors of HIV-1 reverse transcriptase","volume":"67","year":"2002","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224021143_R37","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1095\/biolreprod58.6.1515","article-title":"Spermicidal activity of metallocene complexes containing vanadium(IV) in humans","volume":"58","year":"1998","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224021143_R38","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S0015-0282(01)01992-6","article-title":"Effect of pretreatment of semen with pokeweed antiviral protein on pregnancy outcome in the rabbit model","volume":"76","year":"2001","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170224021143_R39","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0010-7824(98)00059-6","article-title":"Contraceptive testing of vaginal agents in rabbits","volume":"58","year":"1998","journal-title":"Contraception"},{"key":"key\n\t\t\t\t20170224021143_R40","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1080\/01926230290168551","article-title":"A 13-week subchronic intravaginal toxicity study of the novel broad-spectrum anti-HIV and spermicidal agent, N-[2-(1-cyclohexenyl)ethyl]-N\u2032-[2-(5-bromopyridyl)]-thiourea (PHI-346) in mice","volume":"30","year":"2002","journal-title":"Toxicologic Pathol"},{"key":"key\n\t\t\t\t20170224021143_R41","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1095\/biolreprod62.4.939","article-title":"Studies in humans on the mechanism of potent spermicidal and apoptosis-inducing activities of vanadocene complexes","volume":"62","year":"2000","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224021143_R42","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1095\/biolreprod60.6.1419","article-title":"Novel derivatives of phenethyl-5-bromopyridylthiourea and dihydroalkoxybenzyloxopyrimidine are dual-function spermicides with potent anti-HIV activity","volume":"60","year":"1999","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224021143_R43","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00001813-200011000-00009","article-title":"Apoptosis-inducing oxovanadium(IV) complexes of 1,10-phenanthroline against human ovarian cancer","volume":"11","year":"2000","journal-title":"Anticancer Drugs"},{"key":"key\n\t\t\t\t20170224021143_R44","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1530\/jrf.0.0200085","article-title":"Comparison of vaginal tolerance tests of spermicidal preparations in rabbits and monkeys","volume":"20","year":"1969","journal-title":"J Reprod Fertil"},{"key":"key\n\t\t\t\t20170224021143_R45","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1095\/biolreprod.103.019182","article-title":"Development and evaluation of a thermoreversible ovule formulation of stampidine, a novel nonspermicidal broad-spectrum anti-human immunodeficiency virus microbicide","volume":"69","year":"2003","journal-title":"Biol Reprod"},{"key":"key\n\t\t\t\t20170224021143_R46","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/oxfordjournals.humrep.a136824","article-title":"Human and bovine cervical mucus penetration as a test of sperm function for in-vitro fertilization","volume":"3","year":"1988","journal-title":"Hum Reprod"},{"key":"key\n\t\t\t\t20170224021143_R47","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.1996.03530270050031","article-title":"The emerging genetic diversity of HIV: the importance of global surveillance for diagnostics, research and prevention","volume":"275","year":"1996","journal-title":"JAMA"},{"key":"key\n\t\t\t\t20170224021143_R48","volume-title":"Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences.","year":"1999"},{"key":"key\n\t\t\t\t20170224021143_R49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1089\/aid.1998.14.157","article-title":"Drug susceptibility of subtypes A, B, C, D, and E human immunodeficiency virus type 1 isolates","volume":"14","year":"1998","journal-title":"AIDS Res Hum Retroviruses"},{"key":"key\n\t\t\t\t20170224021143_R50","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1097\/00126334-200108150-00005","article-title":"Adefovir and tenofovir susceptibilities of HIV-1 after 24 to 48 weeks of adefovir dipivoxil therapy: genotypic and phenotypic analyses of study GS-96-408","volume":"27","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"key\n\t\t\t\t20170224021143_R51","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1046\/j.1537-2995.2000.40111399.x","article-title":"Surveillance of HIV-1 genetic subtypesand diversity in the US blood supply","volume":"40","year":"2000","journal-title":"Transfusion"},{"key":"key\n\t\t\t\t20170224021143_R52","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1056\/NEJM200003303421303","article-title":"Viral load and heterosexual transmission of human immunodeficiency virus type 1","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20170224021143_R53","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/0140-6736(92)92495-2","article-title":"Insemination of HIV-negative women with processed semen of HIV-positive partners","volume":"340","year":"1992","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20170224021143_R54","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0015-0282(98)00102-2","article-title":"Human immunodeficiency virus type 1-serodiscordant couples can bear healthy children after undergoing intrauterine insemination","volume":"70","year":"1998","journal-title":"Fertil Steril"},{"key":"key\n\t\t\t\t20170224021143_R55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00002030-199902040-00003","article-title":"Sexual transmission of HIV: infectiousness and prevention","volume":"13","year":"1999","journal-title":"AIDS"},{"key":"key\n\t\t\t\t20170224021143_R56","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.virol.2004.04.013","article-title":"Differential virus evolution in blood and genital tract of HIV-infected females: evidence for the involvement of drug and non-drug resistance-associated mutations","volume":"324","year":"2004","journal-title":"Virology"},{"key":"key\n\t\t\t\t20170224021143_R57","volume-title":"Techniques of Solubilization of Drugs","year":"1981"},{"key":"key\n\t\t\t\t20170224021143_R58","first-page":"238","article-title":"Compendium of excipients for parenteral formulations","volume":"52","year":"1998","journal-title":"PDA J Parenter Sci Technol"},{"key":"key\n\t\t\t\t20170224021143_R59","volume-title":"Pharmaceutical Excipients.","year":"2000"},{"key":"key\n\t\t\t\t20170224021143_R60","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2340\/0001555577026028","article-title":"Use of XTT-assay to assess the cytotoxicity of different surfactants and metal salts in human keratinocytes (HaCaT). A feasible method for in vitro testing of skin irritants","volume":"77","year":"1997","journal-title":"Acta Derm Venereol"},{"key":"key\n\t\t\t\t20170224021143_R61","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/(SICI)1099-1263(199905\/06)19:3<163::AID-JAT561>3.0.CO;2-H","article-title":"Comparison of cytotoxicity of various surfactants tested on normal human fibroblast cultures using the neutral red test, MTT assay and LDH release","volume":"19","year":"1999","journal-title":"J Appl Toxicol"},{"key":"key\n\t\t\t\t20170224021143_R62","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0008-6215(00)85885-1","article-title":"Structure of extracellular polysaccharide from Xanthamonas comopestris","volume":"45","year":"1975","journal-title":"Carbohydr Res"}],"container-title":["Biology of Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/biolreprod\/article-pdf\/71\/6\/2037\/10645907\/biolreprod2037.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,14]],"date-time":"2024-01-14T18:03:21Z","timestamp":1705255401000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/biolreprod\/article-lookup\/doi\/10.1095\/biolreprod.104.032870"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12,1]]},"references-count":62,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2004,12,1]]}},"URL":"https:\/\/doi.org\/10.1095\/biolreprod.104.032870","relation":{},"ISSN":["0006-3363","1529-7268"],"issn-type":[{"value":"0006-3363","type":"print"},{"value":"1529-7268","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12,1]]}}}